The article discusses whether investors can seek damages under federal securities laws even if other remedies are available. It looks at how the Supreme Court has interpreted these laws and the implications for defrauded investors. The focus is on whether remedies should be exclusive or cumulative, especially in cases of fraudulent conduct. The researchers argue that allowing overlap in remedies for fraud cases is important, but not for violations related to reporting requirements.